The US Food and Drug Administration (FDA) has approved a blood test that can help predict preeclampsia, a serious hypertensive disorder that affects roughly 2 per cent to 8 per cent of pregnant women worldwide.
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.